INTRODUCTION {#S1}
============

Relay of muscle-derived sensory information from the periphery to the CNS is essential for coordinating motor output during behavior and plays essential roles during motor learning and adaptation ([@R10]; [@R51]). The role of proprioception in motor control has been investigated in animal studies where sensory neurons have been genetically or surgically ablated, as well as in sensory neuropathies that disrupt proprioceptive feedback ([@R17]). While basic motor functions such as walking and reaching are retained, loss of proprioception causes severe defects in limb coordination. In humans with sensory deficits, the ability to move the arm is maintained but characterized by the inability to predict and correct errors ([@R21]; [@R23]). Ablation of hindlimb proprioceptive input leads to a loss of inter-joint limb coordination, as well as defects in the ability of animals to adapt locomotor behaviors when confronted with uneven terrains ([@R1]; [@R2]; [@R53]).

Muscle- and joint-derived sensory information is relayed to the CNS through specialized classes of proprioceptive sensory neurons (pSNs) that connect peripherally with muscle spindles and Golgi tendon organs ([@R12]). Centrally, pSNs establish connections with diverse arrays of neuronal subtypes, including spinal motor neurons (MNs), local circuit interneurons, and ascending projection neurons. Ascending pathways relay information related to muscle contractile status to higher brain centers, including the cerebellum. Proprioceptive sensory streams are transmitted to the cerebellum through neurons that project along the spinocerebellar and cuneocerebellar tracts ([@R10]; [@R42]). Spinal projections originating from spinocerebellar tract neurons (SCTNs) terminate as mossy fibers and constitute a major source of input to cerebellar granule cells.

Anatomical tracing studies in mammals indicate that SCTNs comprise up to a dozen distinct subtypes that are located at discrete positions along the rostrocaudal axis of the spinal cord ([@R4]; [@R34]; [@R35]; [@R45]). Electrophysiological studies, predominantly in cats and rats, have shown that each SCTN type is targeted by pSNs that innervate specific muscle groups. For example, neurons within Clarke's column (CC) relay proprioceptive information from hindlimb muscles, the central cervical nucleus from the neck, and Stilling's sacral nucleus from the tail ([@R19]; [@R31]; [@R42]). While specific SCTN populations convey sensory information related to the activity of broad muscle groups, individual neurons within CC appear to receive sensory inputs from multiple, and often functionally antagonistic, limb muscle types ([@R30]; [@R39]). The information relayed from pSNs to CC may provide more global information about limb parameters, such as direction of limb movement and orientation, as opposed to muscle- specific features ([@R42]). In addition to input from pSNs, neurons within CCs receive direct excitatory and indirect inhibitory input from corticospinal neurons ([@R24]). The coincidence of cortical- and muscle-derived inputs suggests that SCTNs function as local hubs that integrate and process sensory and motor information.

Despite progress in elucidating the anatomical organization and physiological features of SCTNs, the molecular basis for their subtype diversification and connectivity is largely unknown. In principle, SCTN diversification could employ the same developmental mechanisms that have been defined for other neuronal classes, such as spinal MNs. All spinal MNs arise from a single progenitor domain but give rise to dozens of topographically organized muscle-specific subtypes ([@R41]). This diversity is established through the activities of Hox transcription factors along the rostrocaudal axis. *Hox* genes are expressed by multiple neuronal populations within the hindbrain and spinal cord, suggesting a broader role in neuronal specification. Although recent studies have implicated *Hox* function during the differentiation of interneurons in the ventral spinal cord ([@R25]; [@R48]), the identity of their downstream target effectors and potential roles in sensory-motor circuit assembly have not been investigated.

We used single-cell RNA sequencing to define the molecular signatures of SCTNs generated at cervical and thoracic levels of the spinal cord. We show that the specification of SCTNs relies on segmental-level specific activities of Hox transcription factors, and loss of *Hox* gene function transforms the molecular profiles and connectivity patterns of SCTN subtypes. These results indicate that the specification of SCTNs relies on the same developmental programs used to generate spinal MN subtypes, suggesting a common transcriptional strategy drives cell-type diversification across multiple neuronal classes.

RESULTS {#S2}
=======

Organization and Input Specificity of SCTNs {#S3}
-------------------------------------------

To dissect the molecular profiles of SCTN subtypes, we first used retrograde tracing from the cerebellum to map the position of SCTNs along the rostrocaudal axis of the spinal cord. We injected Alexa555 conjugated cholera toxin B (CTB) into the cerebellum of P4 mice and allowed SCTNs to be labeled for 2 days. Whole-mount staining of the spinal cord labeled specific subsets of neurons along the rostrocaudal axis ([Figure 1A](#F1){ref-type="fig"}). Prominent columns of neurons were found near the midline of rostral cervical, thoracic, and rostral lumbar levels and more laterally positioned columns at caudal lumbar and sacral levels. More scattered SCTN populations were found throughout the entire length of the spinal cord. We mapped the distribution of SCTNs within specific spinal segments and generated contour maps of SCTN densities at cervical, thoracic, lumbar, and sacral levels ([Figures 1B](#F1){ref-type="fig"} and [1C](#F1){ref-type="fig"}). Consistent with previous studies, four prominent clusters of SCTNs were labeled, including the central cervical nucleus (CCN) at rostral cervical levels, CC neurons extending from thoracic to rostral lumbar levels, spinal border cells (SBCs) at lumbar levels, and Stilling's nucleus (SSN) at sacral levels ([@R19]; [@R35]; [@R45]). We also identified SCTNs showing more distributed patterns at cervical levels in Rexed lamina (L)V, LVI, and LVII and at lumbar levels in LV, LVII, and LVIII ([Figure 1C](#F1){ref-type="fig"}). Collectively, these tracing data identify 10 major groups of SCTNs in early postnatal mice ([Figures 1E](#F1){ref-type="fig"}; [Figure S1](#SD1){ref-type="supplementary-material"}).

SCTNs are essential for relaying proprioceptive sensory information from muscle to cerebellum, but the muscle-specific inputs that SCTNs receive are largely unmapped in mouse. We examined the source of inputs from pSNs to SCTNs by injection of CTB into specific muscles while in parallel labeling SCTNs with either cerebellar retrograde tracing or using SCTN-restricted molecular markers. Selectivity of proprioceptive inputs was further delineated by localization with VGluT1, which labels the presynaptic boutons of pSNs ([@R8]; [@R46]). This analysis revealed that SCTNs receive input from discrete muscle types and are consistent with studies in rat and cat ([@R19]; [@R33]; [@R42]; [@R46]). Rostral cervical CCN neurons receive inputs from pSNs innervating neck muscles, and caudal cervical LVII SCTNs receive input from forelimb muscle, while thoracic and upper lumbar CC neurons receive input from hindlimb and ventral hypaxial muscles ([Figure 1B](#F1){ref-type="fig"}). Inputs to SBC neurons were not labeled through any of the muscle injections we attempted and did not contain VGluT1+ presynaptic boutons, as previously reported (data not shown) ([@R46]). These results indicate that specific populations of SCTNs can be delineated by their rostrocaudal position, settling location, and the source of their inputs from specific muscle groups.

Molecular Profiling of SCTNs at Cervical and Thoracic Levels {#S4}
------------------------------------------------------------

To determine whether SCTN subtypes can be distinguished by differences in molecular profiles, we performed RNA sequencing (RNA-seq) on retrogradely labeled and individually isolated SCTNs from cervical and thoracic levels ([Figure 2A](#F2){ref-type="fig"}). To obtain high sequencing depth, we first performed RNA-seq on pools of labeled SCTNs. We collected four pools, each containing \~200 cervical SCTNs, and four pools of \~350 thoracic SCTNs. We identified 1,768 genes that were enriched in cervical SCTNs and 495 genes enriched in thoracic SCTNs (\>2-fold change; Benjamini-Hochberg \[BH\]-adjusted p \< 0.05) ([Figure 2B](#F2){ref-type="fig"}). Differentially expressed genes included effector molecules with implications for neural function including ion channels, neuropeptide receptors, and neurotransmitter transporters ([Figure 2C](#F2){ref-type="fig"}). For example, selective expression of neuropeptides and associated proteins was found in cervical SCTNs (e.g., *NPY*, *Tac1*, *Pnoc*, *pdyn*, *qrfp*, and *scg2*) and thoracic SCTNs (*NTS*), suggesting that SCTN subtypes differentially release more than one neuromodulator. This dataset will be useful for testing hypotheses about anatomical and physiological differences between cervical and thoracic SCTN populations.

We further characterized genes differentially expressed between cervical and thoracic SCTNs by performing mRNA *in situ* hybridization and immunohistochemical analyses ([Figure 2D](#F2){ref-type="fig"}). We focused on transcription factors, cell adhesion molecules, and genes implicated in neuronal function, as these classes of genes are often selectively expressed by neuronal subtypes. Most of the cervical enriched genes we identified were expressed in a cluster of neurons located in rostral cervical segments, near the position occupied by CCN neurons. Putative CCN-restricted genes included *Foxp2*, *Pou4f1*, *Gpr88*, *Ndnf*, and *Pcdh20* ([Figures 2D](#F2){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}). We confirmed selective expression of *Foxp2* in CCN neurons by performing cerebellar retrograde tracing of SCTNs in conjunction with Foxp2 antibody staining. This analysis revealed Foxp2 is expressed by labeled SCTNs at rostral cervical levels but not in caudal cervical or thoracic SCTNs ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). We also identified a number of genes selective for thoracic CC neurons, including the previously characterized *Gdnf* and *VGlut1* genes ([@R24]). We confirmed SCTN-restricted expression of additional genes, including *Lrrn1*, *Chmp2b*, *Syt4*, and *Ebf3*, by performing *in situ* hybridization or immunohistochemistry in conjunction with cerebellar CTB tracing ([Figures 2D](#F2){ref-type="fig"} and [S2B](#SD1){ref-type="supplementary-material"}). These genes were expressed by clusters of thoracic neurons, but not in cervical SCTNs, indicating they are selective markers for CC neurons ([Figure 2F](#F2){ref-type="fig"}; data not shown).

Single-Cell Molecular Profiling of SCTNs {#S5}
----------------------------------------

To further examine the diversification of SCTNs using genomewide assays and to identify smaller subgroups of SCTNs, we performed single-cell RNA-seq on neurons isolated from rostral cervical, caudal cervical, and rostral thoracic levels. We manually isolated \~100 retrogradely labeled SCTNs from each level and performed single cell RNA sequencing (scRNA-seq). Unsupervised clustering of scRNA-seq data identified eight clusters of neurons (SCT1--8) ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}; [Figures S3A](#SD1){ref-type="supplementary-material"} and [S3B](#SD1){ref-type="supplementary-material"}). Two clusters, SCT7 and SCT5, were unique to rostral cervical and rostral thoracic segments and expressed genes indicative of CCN and CC fates, respectively, based on the number and identity of genes that overlapped with our bulk sequencing analyses ([Figure S3C](#SD1){ref-type="supplementary-material"}). For example, SCT7 expresses *Foxp2* (a CCN marker), while SCT5 expresses *Gdnf* (CC marker). Two clusters, SCT2 and SCT3, were present in each of the three segmental levels we analyzed ([Figure 3B](#F3){ref-type="fig"}), possibly representing Hox-independent populations. Four clusters (SCT1, 4, 6, and 8) were present at two levels, with higher representation within a single region. These results potentially identify additional SCTN populations that were likely masked by over-representation of CCN- and CC-restricted genes in our bulk sequence analysis.

To determine whether any of our single-cell clusters identify additional SCTN types, we chose genes within cluster SCT1 for further analysis. SCT1 neurons derive from caudal cervical segments, possibly representing the LVII SCTN subtype. SCT1 neurons are characterized by elevated expression of *Fam19A4*, *Shox2*, and *Scip* (*Pou3f1*) ([Figure 3D](#F3){ref-type="fig"}). We found that the *Fam19A4* gene was selectively expressed in caudal cervical segments and marked a small group of spinal neurons ([Figure 3E](#F3){ref-type="fig"}). We confirmed expression of *Fam19A4* in cervical LVII SCTNs by performing *in situ* hybridization on spinal cord sections in which SCTNs were labeled through cerebellar retrograde tracing ([Figure S3D](#SD1){ref-type="supplementary-material"}). Using this approach, we also identified the transcription factors *Shox2* and *Scip* as a selective markers for cervical LVII SCTNs. Although both proteins are expressed throughout the rostrocaudal axis of the spinal cord, we found that Shox2 and Scip were selectively expressed by cerebellar-projecting SCTNs at caudal cervical levels ([Figure 3E](#F3){ref-type="fig"}). Collectively, our bulk and single-cell RNA-seq analyses demonstrate that three SCTN subtypes (CCN, cLVII, and CC) can be molecularly distinguished by differential gene expression.

Hox Protein Expression Defines SCTN Subtypes {#S6}
--------------------------------------------

What are the mechanisms that determine the diversity and molecular signatures of SCTN subtypes? Because a major difference between SCTNs is their segmental organization, we examined differences in *Hox* gene expression, known determinants of rostrocaudal patterning in the CNS ([@R41]). In vertebrates, *Hox* genes are organized in four chromosomal clusters, and the position of individual genes within a cluster determines where it is expressed along the rostrocaudal axis. In general, *Hox* genes located at the 3^′^ end of a cluster are expressed rostrally, while those at the 5^′^ end are expressed caudally. Analysis of our scRNA-seq dataset revealed that cervical and thoracic SCTNs follow this co-linear *Hox* pattern. Rostral cervical SCTNs expressed elevated levels of *Hox4-Hox5* gene paralogs (e.g., *Hoxc4*, *Hoxc5*, and *Hoxa5*), and caudal cervical SCTNs expressed *Hox6-Hox8* paralogs (*Hoxc6* and *Hoxc8*), while rostral thoracic SCTNs express *Hox9* genes (*Hoxc9* and *Hoxa9*) ([Figure 4A](#F4){ref-type="fig"}). In addition, certain *Hox* genes were expressed in multiple segments, suggesting specific combinations of Hox proteins contribute to SCTN specification. For example, *Hoxc8* is detected in both caudal cervical and rostral thoracic SCTNs, while *Hoxc6* is expressed by both rostral and caudal cervical SCTNs ([Figure 4A](#F4){ref-type="fig"}; [Figure S4A](#SD1){ref-type="supplementary-material"}).

We further examined Hox protein expression by performing immunohistochemical analyses in which SCTNs were labeled by cerebellar retrograde tracing at P1. This analysis revealed that cervical CCN neurons express Hoxc4, Hoxc5, and low levels of Hoxc6 but lacked Hoxc8 and Hoxc9 expression ([Figure 4B](#F4){ref-type="fig"}; [Figure S4B](#SD1){ref-type="supplementary-material"}). Caudal cervical SCTNs express Hoxc6 and Hoxc8, with subsets expressing Hoxc9. Thoracic CC neurons express Hox9 paralogs (Hoxa9, Hoxc9, and Hoxd9) and Hox10 paralogs (Hoxa10 and Hoxc10) ([Figure 4B](#F4){ref-type="fig"}; [Figures S4B](#SD1){ref-type="supplementary-material"} and [S4C](#SD1){ref-type="supplementary-material"}). Collectively, these observations indicate that specific SCTNs populations can be identified by differential expression of Hox proteins and suggest specific "Hox codes" determine SCTN subtype identity ([Figure 4C](#F4){ref-type="fig"}).

Hox Genes Are Essential for Specifying SCTN Subtype Identity {#S7}
------------------------------------------------------------

To examine a possible functional role of *Hox* genes in SCTN sub type diversification, we analyzed mice in which specific *Hox* genes are mutated. We first analyzed the effects of mutation of the *Hoxc9* gene, which is normally restricted to thoracic CC neurons. Previous studies have shown that *Hoxc9* is a key determinant of MN subtype identity in thoracic segments and is essential for the generation of preganglionic autonomic MNs and repression of more anterior *Hox* genes ([@R14]; [@R28]). We found that in *Hoxc9* mutants expression of CC-restricted genes was markedly reduced at thoracic levels ([Figure 5A](#F5){ref-type="fig"}; [Figure S5A](#SD1){ref-type="supplementary-material"}). Markers normally displaying highly restricted expression in CC neurons, including *Gdnf*, *Syt4*, *Lrrn1*, *Unc5c*, and *Lmo3*, were undetectable in thoracic segments of *Hoxc9* mutants ([Figure 5A](#F5){ref-type="fig"}). Genes that are expressed by CC neurons, but also other spinal populations, such as *Rgs4* and *Id4*, were lost from CC neurons but were preserved in non-SCTN populations (likely representing interneuron populations that do not rely on specific *Hox* genes or are *Hox* independent) ([Figure 5A](#F5){ref-type="fig"}). These observations indicate that *Hoxc9* is necessary for establishing CC-specific gene programs at thoracic levels.

The loss of CC-restricted gene expression in *Hoxc9* mutants suggests *Hox* genes are generally required for deployment of SCTN-subtype-specific programs. To further explore this idea, we examined whether additional *Hox* genes are essential during SCTN diversification. We examined the function of *Hoxc8*, which is expressed by caudal cervical LVII SCTNs and characterized by selective expression of *Fam19A4*. We found that in *Hoxc8* mutants, expression of *Fam19A4* was lost from the spinal cord ([Figure S5B](#SD1){ref-type="supplementary-material"}). Interestingly, expression of Scip and Shox2 were retained by some caudal cervical SCTNs ([Figure S5C](#SD1){ref-type="supplementary-material"}; data not shown), possibly a result of functional compensation by other *Hox* genes. These results indicate that *Hox* genes are essential for the normal specification of SCTN subtypes at cervical and thoracic levels.

The depletion of SCTN markers in *Hox* mutants could be due to the death of these populations at specific segmental levels or a fate switch to an alternate SCTN identity. To assess this at a cellular level, we performed cerebellar retrograde tracing to determine whether any SCTNs are generated in thoracic segments of *Hoxc9* mutants. We injected CTB into the cerebellum of *Hoxc9* mutants and mapped the position of labeled SCTNs. We found that in *Hoxc9* mutants the dorsomedial population of CC neurons is no longer labeled in thoracic segments, with only a small population present at rostral lumbar levels ([Figures 5B](#F5){ref-type="fig"} and [5C](#F5){ref-type="fig"}). SCTNs were labeled in thoracic segments but were scattered and resided in a position similar to those of caudal cervical LVII types ([Figures 5B](#F5){ref-type="fig"} and [5C](#F5){ref-type="fig"}) and were reduced in number (11 ± 1 \[mean ± SEM\] SCTNs in *Hoxc9* mutants \[n = 11 animals\] versus 42 ± 6 in controls \[n = 8\] from rostral to mid- thoracic segments, p \< 0.001). In contrast, the pattern and number of labeled of SCTNs at caudal cervical levels was similar between control and *Hoxc9* mutants (21 ± 4 SCTNs in *Hoxc9* mutants \[n = 11\] versus 28 ± 3 in controls \[n = 8\] at caudal cervical levels, not significant \[n.s.\]), indicating a selective function of *Hoxc9* in thoracic SCTNs. These results indicate that in the absence of *Hoxc9*, thoracic SCTNs acquire the settling characteristics of cervical LVII SCTNs.

CC Is Transformed to a Cervical SCTN Identity in Hoxc9 Mutants {#S8}
--------------------------------------------------------------

The acquisition of LVII neuron characteristics by thoracic SCTNs suggests a possible identity transformation in *Hoxc9* mutants. To examine a potential fate conversion at a molecular level, we assessed global changes in the transcriptomes of SCTNs in absence of *Hoxc9* function. We compared scRNA-seq profiles from rostral thoracic SCTNs isolated from control and *Hoxc9* mutants and compared these with control rostral and caudal cervical SCTN populations ([Figure 6A](#F6){ref-type="fig"}). We found that rostral thoracic SCTNs lacking *Hoxc9* failed to form the CC cluster (SCT5) and the transcript levels of CC-restricted genes were markedly reduced ([Figure 5A](#F5){ref-type="fig"}). The molecular profile of many thoracic SCTNs in *Hoxc9* mutants matched those of caudal LVII SCTNs (SCT1) ([Figures 6B](#F6){ref-type="fig"} and [6C](#F6){ref-type="fig"}). Upregulated genes in *Hoxc9* mutants included those we identified in our scRNA-seq of control caudal cervical SCTNs, including *Hoxc8*, *Fam19A4*, *Scip* (*Pou3f1*), and *Shox2* ([Figure 6D](#F6){ref-type="fig"}). SCT3, which is normally found at all segmental levels, was still present in thoracic SCTNs of *Hoxc9* mutants ([Figure 6B](#F6){ref-type="fig"}), consistent with a specification program that is independent of a specific *Hox* gene or relies on more generic *Hox* activity. These results indicate that in absence of *Hoxc9*, thoracic CC neurons acquire the molecular profile of cervical SCTNs.

To further characterize the transformation of CC neurons in *Hoxc9* mutants, we examined whether genes normally enriched in caudal cervical SCTNs are derepressed at thoracic levels. Consistent with our scRNA-seq data, as well as previous studies on *Hoxc9* function in spinal MNs, Hoxc8 protein was derepressed in thoracic SCTNs of *Hoxc9* mutants ([Figures 7A](#F7){ref-type="fig"} and [7B](#F7){ref-type="fig"}). Retrograde tracing of SCTNs in *Hoxc9* mutants confirmed that labeled thoracic SCTNs ectopically express Hoxc8 ([Figure 7A](#F7){ref-type="fig"}). In addition, expression of Hoxc10 was lost from SCTNs at thoracic levels ([Figure S7A](#SD1){ref-type="supplementary-material"}). We also analyzed expression of Scip and Shox2 proteins, two markers enriched in caudal cervical SCTNs. The number of thoracic SCTNs expressing Scip and Shox2 was markedly increased in *Hoxc9* mutants (9 ± 2 \[mean ± SEM\] Shox2^+^ SCTNs per section in controls \[n = 3\] versus 17 ± 2 in \[n = 7\] *Hoxc9* mutants, and 8 ± 3 Scip^+^ SCTNs in controls \[n = 3\] versus 17 ± in \[n = 6\] *Hoxc9* mutants) ([Figures 7C](#F7){ref-type="fig"}, [7D](#F7){ref-type="fig"}, [S7B](#SD1){ref-type="supplementary-material"}, and [S7C](#SD1){ref-type="supplementary-material"}). In addition, *Fam19A4*, a selective marker for caudal cervical SCTNs, was ectopically expressed in *Hoxc9* mutants ([Figures 7E](#F7){ref-type="fig"} and [7F](#F7){ref-type="fig"}). The transformation of CC neurons to a cervical LVII fate was also observed in rostral thoracic segments of *Nestin::Cre;Hoxc9 flox/flox* mice, indicating this identity switch is due to a neural-specific function of *Hoxc9* and not general defects in early rostrocaudal patterning ([Figures S7D](#SD1){ref-type="supplementary-material"}--[S7F](#SD1){ref-type="supplementary-material"}). Although we cannot formally rule out a selective loss of SCTN number as a contributing factor to the phenotype of *Hoxc9* mutants, our results indicate that a subset acquire both the anatomical settling position and molecular identity of caudal cervical LVII neurons.

We also asked whether loss of *Hoxc8*, which is required for acquisition of cervical LVII SCTN molecular features, leads to a similar transformation in identity. In *Hoxc8* mutants, Hoxc4 and Hoxc5 were derepressed in caudal cervical segments ([Figure S5D](#SD1){ref-type="supplementary-material"}). In addition retrograde tracing from the cerebellum indicated that labeled caudal cervical SCTNs ectopically express *Hoxc4*, suggesting a fate switch to a more rostral identity ([Figure S5E](#SD1){ref-type="supplementary-material"}). However, analysis of CCN marker expression, including *Foxp2* and *Gpr88*, failed to reveal a transformation in SCTN identity (data not shown). The absence of a complete fate transformation in *Hoxc8* mutants is likely due to presence of additional *Hox* genes in caudal cervical segments, leading to an ambiguous Hox code.

Transformation of SCTN Identity Disrupts Spinocerebellar Circuitry {#S9}
------------------------------------------------------------------

Our results indicate that in the absence of *Hoxc9*, thoracic SCTNs are converted to a cervical LVII SCTN molecular identity. We examined whether this switch in transcriptional profile is accompanied by changes in the connectivity between SCTNs, pSNs, and the cerebellum. We first assessed whether the loss of CC identity in *Hoxc9* mutants affects innervation of the cerebellum by SCTN axons. Because the number of thoracic SCTNs is markedly reduced in *Hoxc9* mutants ([Figure 5B](#F5){ref-type="fig"}), we tested whether there is an overall loss of innervation. To label precerebellar SCTN axons, we injected an adeno-associated virus (AAV) expressing GFP under the *synaptophysin* promoter into rostral cervical and thoracic segments and examined axonal termination patterns ([Figure S8A](#SD1){ref-type="supplementary-material"}). In control animals, injections into rostral cervical segments (containing CCN neurons) labeled axons that terminate in lobules 2, 3, 4/5, and 9. Injection of viral tracer into thoracic segments exhibited denser cerebellar innervation that terminated in lobules 2, 3, 4/5, 8 and 9. In *Hoxc9* mutants, the overall density of projections from thoracic segments to the cerebellum was markedly reduced ([Figures S8A](#SD1){ref-type="supplementary-material"} and [8B](#SD1){ref-type="supplementary-material"}). These observations indicate that loss of *Hoxc9* erodes the normal profile of connectivity between thoracic SCTNs and the cerebellum.

Caudal cervical LVII SCTNs receive input from pSNs that target forelimb muscle. If the transformation of CC neurons to a caudal cervical LVII identity switches their connectivity, they might now receive ectopic inputs from the central afferents of forelimb pSNs. We therefore examined whether ectopic thoracic LVII SCTNs receive forelimb muscle input. We injected CTB into forelimb muscles of control and *Hoxc9* mutant animals while in parallel tracing SCTNs through injection of HRP into the cerebellum. Synapses between CTB-traced proprioceptors onto HRP+ SCTNs was determined by costaining with VGluT1. The number of ectopic synapses from limb proprioceptors to thoracic SCTNs was markedly increased in *Hoxc9* mutants (5 ± 1 \[mean ± SEM\] CTB^+^ synapses/HRP^+^ SCTN in *Hoxc9* mutants \[19 cells from n = 4 animals\] versus 0 ± 0 in controls \[24 cells from n = 4 animals\], p \< 0.0001) ([Figure 7G](#F7){ref-type="fig"}). These results indicate that the transformed SCTNs in *Hoxc9* mutants receive presynaptic inputs appropriate for their switch in identity. Because cervical sensory afferents normally project into thoracic spinal segments ([@R5]), this switch in connectivity is likely due to alterations in the local selection of postsynaptic targets and not a consequence of broad changes in sensory central projections. Collectively, these results show that *Hox* genes are essential for the subtype diversification and connectivity of neurons within spinocerebellar circuits.

DISCUSSION {#S10}
==========

Control of movement depends on accurate reporting of muscle and joint contractile status from pSNs to the CNS. Proprioceptive information is relayed to the cerebellum through diverse SCTN subtypes ([@R19]; [@R35]; [@R45]), but the molecular logic by which SCTN identity and connectivity is achieved is largely unknown. By combining single-cell molecular profiling and genetic analyses, we have identified a Hox-dependent genetic program essential for the diversification and synaptic specificity of SCTNs that relay proprioceptive sensory information from limb and axial muscle to the cerebellum. Our findings indicate that the same developmental mechanisms used to generate the diversity of spinal MNs are essential for specifying subtypes of sensory-relay interneurons. These results suggest a general mechanism through which a single large family of transcription factors establishes the diversity of multiple neuronal classes.

Molecular and Anatomical Diversity of SCTNs {#S11}
-------------------------------------------

Using genome-wide interrogation of SCTN subtypes generated at cervical and thoracic levels, we identified molecular signatures that distinguish CCN, cLVII, and CC neurons, three major SCTN subtypes that relay proprioceptive information from neck, forelimb, and hindlimb muscles, respectively. Our scRNA-seq analysis identified eight clusters of neurons, each likely representing a specific SCTN subtype. We found that three of these clusters, SCT1, SCT5, and SCT7 represent cLVII, CC, and CCN subtypes and constitute the majority of SCTN populations generated at cervical and thoracic levels. The additional five clusters we identified could represent smaller subtypes of SCTNs, such as the more scattered populations normally observed at multiple segmental levels. The relatively small number of neurons represented in these clusters precludes definitive identification of their specific SCTN identity. Nevertheless, these populations could encompass SCTN lineages derived from spinal progenitors expressing the transcription factor *Atoh1* ([@R7]; [@R44]), which includes a population recently shown to define a distinct group of non-CC SCTNs ([@R54]).

Role of Hox Genes in Determining SCTN Organization and Subtype-Specific Features {#S12}
--------------------------------------------------------------------------------

Our studies indicate that Hox transcription factors play critical roles in specifying SCTN subtype identity at cervical and thoracic levels. We found that SCTN subtypes can be defined by expression of specific Hox transcription factors. CCN neurons express *Hox5* paralogs, and cLVII neurons express *Hoxc8*, while CC neurons express *Hox9* and *Hox10* genes. Mutation in the thoracic *Hoxc9* gene leads to a loss of CC-specific molecular programs, while mutation in *Hoxc8* erodes the molecular specification of cLVII neurons. In the absence of *Hoxc9*, all molecular features of thoracic CC neuron are depleted, with only lumbar-level expression of these genes being maintained. The preservation of CC identity at lumbar levels suggests multiple *Hox* genes are involved in specifying CC features, which may include additional genes in the *Hox9* and *Hox10* paralog groups. Similarly, the regulation of rostral cervical CCN-restricted determinants likely requires the activities of multiple *Hox5* paralogs.

Recent studies suggest that molecular programs acting along the rostrocaudal axis play key roles in establishing subtype-specific features of spinal interneuron classes. Both V1 and V2a interneuron classes are generated from a single progenitor domain but give rise to dozens of molecularly distinct subtypes, which can be defined through differences in settling position, connectivity, and transcription factor gene expression ([@R9]; [@R20]; [@R25]; [@R48]). While studies of V1 interneurons have demonstrated an important role of *Hox* genes in patterning transcription factor expression ([@R48]), the identities of their subtypespecific targets and roles in circuit assembly are unclear. We found that in the absence of *Hoxc9*, expression of dozens of CC-restricted markers are markedly reduced. In both *Hoxc8* and *Hoxc9* mutants, more rostrally expressed *Hox* genes are derepressed, similar to the boundary-maintenance function of Hox proteins observed in MNs ([@R41]). This leads to either a transformation in SCTN fate as in *Hoxc9* mutants or a disruption in normal specification programs, as seen in *Hoxc8* mutants. These findings suggest that similar to MNs, the diversification of spinal interneuron classes relies on Hox-dependent transcriptional networks to both activate and repress repertoires of subtype-specific genes.

Establishing Synaptic Specificity in Proprioceptive Sensory Circuits {#S13}
--------------------------------------------------------------------

Our studies provide insights into developmental mechanisms through which proprioceptive circuits are assembled. After entering the spinal cord, pSNs establish highly specific connections to diverse classes of postsynaptic targets. The best-studied pSN connections are those established with MNs ([@R12]; [@R13]). Each pSN forms a specific connection to the MN pool that targets the same or functionally related muscle, while avoiding MNs targeting antagonistic muscles. These connections are highly selective, such that a single pSN targets each of the \~50--100 MNs within the entire pool that supplies the same peripheral muscle ([@R37]).

How the striking synaptic specificity between pSNs and their central synaptic targets is achieved is poorly understood but appears to involve both genetic and activity-dependent processes ([@R38]; [@R40]). Mutations in genes involved in pSN fate determination, such as the transcription factors *Er81* or *Runx3*, lead to widespread defects in the connectivity and survival of pSNs ([@R3]; [@R16]; [@R27]). Recent studies indicate that postsynaptic, target-derived cues shape the specificity between pSN and MNs ([@R47]; [@R52]). For example, transforming the identity of thoracic MNs to a limb-level fate, through deletion of the *Hoxc9*, causes limbderived pSNs to target MNs present at thoracic levels ([@R5]). These observations indicate that subtype identity of postsynaptic targets plays an instructive role in determining connectivity with pSNs.

In contrast to the selective connectivity between pSNs and MNs, connections between pSNs and SCTNs appear to be less specific. Neurons within CC receive direct and indirect proprioceptive inputs from multiple, often functionally antagonistic, limb muscle groups ([@R30]; [@R39]). Nevertheless, the specificity of inputs from pSNs to SCTNs could be restricted by the identity of the muscle source (e.g., forelimb versus hindlimb). We found that transformation of SCTNs identities leads to changes in their pre- and postsynaptic connectivity. In *Hoxc9* mutants, forelimb pSNs synapse with cLVII neurons ectopically generated in thoracic segments. These results parallel the circuit alterations between pSNs and MNs observed in *Hoxc9* mutants, where forelimb pSNs synapse with the ectopically generated thoracic lateral motor column MNs ([@R5]). It appears therefore that as pSN axons enter the spinal cord, target specificity is shaped by recognition of molecular differences in the subtypes of neurons they encounter. Although we cannot rule out changes in the cellular environment as a contributing factor to the altered pSN connections to SCTNs in *Hoxc9* mutants, similar changes in pSN connectivity are observed when *Hoxc9* is selectively removed from MNs ([@R5]), suggesting that sensory afferents actively seek out postsynaptic targets of the appropriate molecular identity. Similar Hox-dependent genetic programs within the spinal cord could shape synaptic specificity in multiple circuits, including descending motor and local cutaneous sensory pathways.

A notable feature of CC is an absence of registry between its segmental position and the location of the pSNs from which it receives direct input. Most CC neurons are located at thoracic levels, while hindlimb pSNs reside in lumbar segments. This positional mismatch could be attributed to a change in CC function during vertebrate evolution. One possibility is that SCTNs with CC-like molecular features were initially used for relaying proprioceptive information from axial muscle. In fish, reptiles, and amphibians, axial muscles play prominent roles in coordinating locomotor behaviors and likely required spinocerebellar pathways during motor control. The appearance of paired appendages might have attenuated the importance of axial proprioception, while hindlimb pSNs co-opted the existing thoracic system for limb-based locomotion. The *Hoxc9* gene appears to exert an important role in maintaining this ancestral SCTN genetic program, in part by suppressing expression of *Hox* genes associated with forelimb-level spinal neurons. The organization of SCTNs into clustered groups was likely a later mammalian innovation, as cervical and thoracic SCTNs of amphibians and reptiles do not appear to form longitudinal columns ([@R6]; [@R22]). SCTN organization may have evolved in mammals to facilitate additional layers of interconnectivity, such as those with descending motor pathways or between different types of sensory afferents.

Studies in humans and animal models indicate that loss of muscle-derived sensory information does not prohibit the ability of spinal circuits to generate basic motor output but is essential for adaptive behaviors and motor learning. The relative contributions of proprioceptive input to local spinal networks versus ascending pathways in motor control are unclear. Mice that lack muscle spindles or pSNs display defects in locomotor coordination ([@R2]; [@R3]; [@R50]), but whether this is due to alteration in pSN connections to spinal neurons, spinocerebellar circuits, or both is unknown. The identification of selective molecular features of SCTNs should provide means to ascertain the relative contributions of spinal and supraspinal proprioceptive pathways to motor control. These studies may provide insights into how sensorymotor information is integrated at the level of the spinal cord, as well as basic insights relevant to the study of spinocerebellar ataxias.

STAR★METHODS {#S14}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S15}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jeremy Dasen (<jeremy.dasen@nyumc.org>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S16}
--------------------------------------

### Mouse Genetics {#S17}

Animal work was approved by the Institutional Animal Care and Use Committee of the NYU School of Medicine in accordance with NIH guidelines. Mouse lines used were: *Hoxc9 flox* ([@R5]), *Hoxc9*−*/*− ([@R28]), *Hoxc8*−*/*− ([@R11]), *Nestin::Cre* (The Jackson Laboratory, \#003771), FVB (\#207, Charles River Lab). Because we observed no phenotypic differences between wild-type and *Hoxc9+/*− animals, both genotypes are considered controls. Unless indicated otherwise, all comparisons between control and *Hox* mutants were made between littermates. No phenotypic differences between male and female animals are expected, but were not formally tested.

METHODS DETAILS {#S18}
---------------

### Immunohistochemistry {#S19}

For antibody staining of sections, slides were first placed in PBS for 5 minutes to remove OCT. Sections were then transferred to humidified trays and blocked for 20--30 minutes in 0.75 ml/slide of PBT (PBS with 0.1% Triton) containing 1% Bovine serum albumin (BSA). The blocking solution was replaced with primary staining solution containing antibodies diluted in PBT with 0.1% BSA. Primary antibody staining was performed overnight at 4°C. Slides were then washed three times for 5 minutes each in PBT. Fluorophore-conjugated secondary antibodies were diluted 1:1000--1:2000 in PBT and filtered through a 0.2 μm syringe filter. Secondary antibody solution was added to slides (0.75 ml/slide) and incubated at room temperature for 1 hour. Slides were washed three times in PBT, followed by a final wash in PBS. Coverslips were placed on slides using 110 μL of Vectashield (Vector Laboratories).

Antibodies against Hox proteins have been previously described ([@R14], [@R15]).

### *In situ* hybridization {#S20}

*In situ* hybridization of tissue sections was performed as previously described using DIG labeled probes ([@R29]). For *in situ* hybridization sections were first dried for 10--15 minutes at room temperature, placed in 4% PFA, and fixed for 10 minutes at room temperature. Slides were then washed three times for 3 minutes each in PBS, and then placed in Proteinase K solution (1 μg/ml) for 5 minutes at room temperature. After an additional PFA fixation and washing step, slides were treated in triethanolamine for 10 minutes, to block positive charges in tissue. Slides were then washed three times in PBS and blocked for 2--3 hours in hybridization solution (50% formamide, 5X SSC, 5X Denhardt's solution, 0.2 mg/ml yeast RNA, 0.1 mg/ml salmon sperm DNA). Prehybridization solution was removed, and replaced with 100 μL of hybridization solution containing 100 ng of DIG-labeled antisense probe. Slides were then incubated overnight (12--16 hours) at 72°C in humidified chambers. Primer sequences used for amplification of probes are listed in [Table S1](#SD1){ref-type="supplementary-material"}.

After hybridization, slides were transferred to a container with 400 mL of 5X SSC and incubated at 72°C for 20 minutes. During this step, coverslips were removed using forceps. Slides were then washed in 400 mL of 0.2X SSC for 1 hour at 72°C. Slides were transferred to buffer B1 (0.1 M Tris pH 7.5, 150 mM NaCl) and incubated for 5 minutes at room temperature. Slides were then transferred to staining trays and blocked in 0.75 ml/slide of B1 containing 10% heat inactivated goat serum. The blocking solution was removed and replaced with antibody solution containing 1% heat inactivated goat serum and a 1:5000 dilution of anti-DIG-AP antibody (Sigma-Aldrich). Slides were then incubated overnight at 4°C in a humidified chamber. The following day, slides were washed 3 times, 5 minutes each, with 0.75 ml/slide of buffer B1. Slides were then transferred to buffer B3 (0.1 M Tris pH 9.5, 100 mM NaCl, 50 mM MgCl~2~) and incubated for 5 minutes. Slides were then developed in 0.75 ml/slide of B3 solution containing 3.5 μl/ml BCIP and 3.5 ml/ml NBT for 12--48 hours. After color development, slides were washed in ddH~2~0 and coverslipped in Glycergel (Agilent). A more detailed *in situ* hybridization protocol is available on our lab website (<https://med.nyu.edu/dasenlab>).

### SCTNs labeling {#S21}

SCTNs were labeled by injecting CTB (Alexa555 conjugated form, 1μg/μl in PBS, Cat\# C34775, Invitrogen) throughout the cerebellum using NanojetII (Cat\# 3-000-204, Drummond Scientific Company) at P4 and examined at P6--P7. Labeled SCTNs were collected manually as described ([@R26]) with some modifications: before pronase incubation meninges were removed as much as possible and 150--300mm transverse spinal cords slices were generated using a razor blade.

### SCTN Bulk RNA Sequencing and Analysis {#S22}

Retrograde labeled spinal cord slices were incubated in ACSF (126mM NaCl, 3mM KCl, 1.25mM NaH2PO4, 20mM NaHCO3, 20mM D-Glucose, 2mM CaCl2, 2mM MgCl2 w/ pronase) for 50min. During cell collection for bulk sequencing, neuronal activity blockers were not included in ACSF. Sorted cells were transferred to tubes containing 50ml Picopure RNA extraction buffer. RNAs were extracted and spiked in ERCCs. Sequencing libraries were prepared using NuGEN SPIA library prep kit. Quadruplicates of pooled samples were used for bulk sequencing: Cervical (C1--C8;185, 182, 179, 178cells)/Thoracic (T1--T12, 310, 305, 473, 341 cells).

All bulk RNA-seq reads were aligned to the GRCm38 (mm10) reference genome, using the STAR alignment package ([@R18]) with default parameters. Differential gene expression analysis was carried out on the raw count data using the edgeR software package ([@R36]). Differentially expressed genes were called at an FDR (Benjamini-Hochberg) corrected p value \<0.05. Unless stated otherwise, all expression values in figures are in transcripts per million (TPM). For genes plotted in figures, the corresponding log-fold change thresholds are indicated in the figure caption.

### Single Cell RNA Sequencing and Analysis {#S23}

During cell collection for single cell RNA sequencing, neuronal activity blockers (TTX, APV, and DNQX) were included in ACSF as described ([@R26]). Slices were incubated in ACSF (w/ pronase) for 50min. After dissociation of labeled cells, each cell was transferred to 0.2 mL PCR 8-tube strip (1402--4700, USA Scientific) containing 3 ul lysis buffer (0.2% Triton X-100 (Cat\#T8787--100ML, Sigma Aldrich) in Nuclease-free water (Cat\#AM9937, Ambion) with 0.1 U/ul RNase inhibitor (Cat\#30281--1, Lucigen). During cell transfer, 0.1--0.2 ul ACSF cocktail was transferred to the collection tube. Each 8-tube strip of cells was flash frozen on dry ice and kept at −80°C until sequencing experiment was performed. Number of cells used in single cell sequencing: MRT (T2--T8), 125 cells; CRT (T2--T8), 78 cells; CCC (C5--T1), 53 cells; CRC (C1--C4), 23 cells. All cells were processed and prepared for sequencing in parallel. RNaseq data is available through GEO (accession in progress).

All single-cell RNA-seq reads were aligned to the GRCm38 (mm10) reference genome, using the STAR alignment package. Reads were collapsed by Unique Molecular Identifier (UMI) on a gene- and sample-wise basis using the DropSeqtools package with standard parameters. Cells with \< 4,000 genes detected were removed, and all UMI values were normalized to transcripts per million (TPM) for clustering. Given the high detection of genes and UMIs, no dropout correction was implemented before clustering. Grouping of single cells into putative clusters was performed using an iterative gene-clustering based approach implemented in the hicat clustering package ([@R49]). Briefly, high variance genes were identified (as those with variance greater than technical noise, as defined by variance in ERCC spike-in controls) and these genes were then clustered using a variant of Weighted Gene Co-Expression Network Analysis. The gene modules derived from this clustering were used as the reduced dimensions on which to cluster cells. Cells were clustered hierarchically using a Euclidean distance metric (on the reduced dimensions), and the resulting dendrogram was divided into clusters with the cutreeDynamic R function with the cutHeight parameter set to 0.99. The resulting clusters from this tree-cutting step were then evaluated for differential gene expression, and clusters with a total log10(p value) \< 100 for all differentially expressed genes (p value \< 0.05) were re-merged. Clusters containing fewer than 4 cells were merged with their parent clusters. Given that the clustering in both [Figure 3](#F3){ref-type="fig"} (wild-type only) and [Figure 6](#F6){ref-type="fig"} (joint wild-type and mutant) showed clusters with mixed membership of regions and conditions, no computational batch correction was performed.

### SCTN and Sensory Terminal Labeling {#S24}

SCTNs were labeled by injecting HRP (20%, 100mg HRP (Cat\# 814 407, Roche) dissolved in 1% Lysophosphatidyl choline (Cat\# L4129, Sigma Aldrich) into the cerebellum and muscle sensory terminals were labeled by CTB (2% CTB; Cat\# C9903, Sigma-Aldrich) injection into the muscle at P4. Samples were perfused (4% PFA), saturated with sucrose (30%), and cryosectioned at 30um. Signals were examined at P6 using immunohistochemistry.

### Spinal AAV Injections {#S25}

Retrograde AAV variant (0.5μl, *AAV-SL1-synGFP*, gift from Janelia Research Campus) was injected into the spinal cord at P1 using NanojetII and examined at P6. Injected samples were perfused (4% PFA), saturated with sucrose (30%), and cryosectioned at 40um.

### Image Acquisition {#S26}

Zeiss confocal microscope (LSM700, 20X dry or 63X oil objective lenses) was used for acquiring images. Images were processed in Fiji and Photoshop.

### Contour Plots {#S27}

Images were fit to the representative spinal cord sections using the landmark correspondence plugin in ImageJ. X--Y coordinates were acquired in ImageJ. Isoline plots were generated from X--Y scatterplots using Bivariant Kernel Density Estimation function (gkde2) with default setups in MATLAB. Nine isolines (from yellow to blue) were generated by default: yellow line, most dense region; blue line, least dense region.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S28}
---------------------------------------

Statistical analysis was performed using Prism 7 software. Normality test was performed before sample comparison (Shapiro-Wilk normality test or D'Agostino & Pearson normality test). If samples were met normality criteria, samples were compared using two tailed Student's t test; if not, non-parametric (Wilcoxon--Mann--Whitney) tests were used.

DATA AND SOFTWARE AVAILABILITY {#S29}
------------------------------

RNaseq data and analyses were deposited into the GEO repository under accession numbers GEO: GSE129948 and GEO: GSE130312.
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![Distribution and Muscle-Specific Inputs of SCTNs\
(A) Whole mount of Alexa555-CTB labeled SCTNs in P6 mouse spinal cord. Injection schematic is shown on the right. Ce, cervical; Th, thoracic; Lu, lumbar.\
(B) CTB-labeled SCTNs in spinal cord sections. Shown are the matched regions to the whole-mount spinal cord. Last two sections are from sacral regions. Choline acetyl transferase (ChAT) staining indicates MN position. Scale bars, 100 μm.\
(C) Density plots of labeled SCTNs. Contour plots were generated from n = 6 spinal cords. Number of cells in each section, from left to right (rostral cervical to sacral), is 299, 165, 251, 241, 376, 662, 266, 78, 161, and 92. Distance, μm.\
(D) Sensory inputs to SCTNs traced by CTB injection into indicated target muscle. Shown are the magnified images of regions demarked by white dashed lines. VGluT1 labels pSN terminals, A555-CTB labels traced SCTNs, and Chmp2b marks CC neurons (found in Allen brain atlas). Injection schematic is shown on the right. Scale bars, 25 μm.\
(E) Summary of SCTN organization in mouse.\
Images in (A) and (D) are tiled composites made in Zen software. See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0002){#F1}

![Identification and Characterization of CCN and CC Molecular Markers\
(A) Strategy for isolating cervical and thoracic SCTNs for RNA-seq. Isolations were performed in quadruplicate at cervical (185, 182, 179, 178 SCTNs) and thoracic (310, 305, 473, 341 SCTNs) levels.\
(B) Mean expression of differentially expressed genes in cervical (x axis) and thoracic (y axis) bulk RNA-seq samples. Genes with differential expression between cervical and thoracic samples with false discovery rate (FDR) \< 0.001 (using edgeR), fold-change \> 2, and mean transcripts per million (TPM) \> 10 in either cervical or thoracic samples are shown as dots, colored by FDR value. Genes with fold-change greater than 30 are shown with text labels.\
(C) Heatmaps showing expression of differentially expressed genes (cervical versus thoracic, FDR \< 0.001, fold-change \> 2) belonging to major annotated categories. Heatmap colors represent scaled TPM values for each replicate bulk sample.\
(D) Validation of sequencing data by *in situ* hybridization and immunostaining. For identifying SCTNs by immunostaining, Alexa555-CTB labeled spinal cord sections were used.\
(E and F) Expression of Foxp2 (E) and Lrrn1 (F) in retrogradely labeled SCTNs at rostral cervical (rCe), caudal cervical (cCe), and caudal thoracic (cTh) segments. Low-magnification images in (E) and (F) are composites of tiled images generated in Zen and are matted on a black background. Images to right of these panels show higher magnification of boxed area.\
Scale bars in (D), (E), and (F), 100 mm. See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0003){#F2}

![Characterization of SCTN Subtypes by scRNA-seq\
(A) scRNA-seq workflow. Alexa555-CTB labeled SCTNs were isolated from rostral cervical (rCe), caudal cervical (cCe), and rostral thoracic (rTh) spinal cord at P7.\
(B) Visualization of putative cell clusters in a t-Distributed Stochastic Neighbor Embedding (t-SNE) plot. Cells were clustered as described in the methods (not in t-SNE space), and cluster identities SCT1 through SCT8 are color-coded in the plot. Shapes represent the dissection from which cells were obtained.\
(C) Dot plot showing the number of cells in each cluster deriving from each segmental dissection. The size of each circle indicated the number of cells in a given cluster from a specific dissection, and the corresponding numbers are indicated to the right of the circles.\
(D) Barplot showing the expression (TPM) values for selected pan-class genes and genes with differential expression across clusters. The hierarchical dendrogram at the top was generated using complete linkage, with the distance metric defined as the Euclidean distance between mean log10(TPM+1) values for each cluster. For each gene, the maximum TPM value is indicated by the number to the right of each row in the bar plot.\
(E) Expression of *Fam19A4*, Scip, and Shox2 in cCe SCTNs. For Scip and Shox2 analyses, SCTNs were labeled by cerebellar-CTB (cbCTB) retrograde tracing. Images in (E) are tiled images generated in Zen and are matted on black background.\
Scale bars, 100 μm. See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0004){#F3}

![Hox Expression Patterns within SCTN Subtypes\
(A) Plots of scRNA-seq data showing *HoxC* and *HoxA* cluster gene expression levels (TPM) in each segmental region. Only *Hox4-Hox10* paralogs are shown, and gene names are abbreviated (e.g., C4 = *Hoxc4*). rCe, 18 cells; cCe, 34 cells; rTh 66 cells. Solid lines indicate mean TPM; error bars indicate ± SEM.\
(B) Hox protein expression in SCTN subtypes at cervical and thoracic levels. SCTNs were labeled by injection of Alexa555-CTB into the cerebellum at P1 and analyzed using indicated Hox antibodies at P2. Images are tiled composites generated in Zen and are matted on a black background. Scale bars, 100 μm.\
(C) Summary of *HoxC* gene expression in cervical and thoracic SCTNs.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0005){#F4}

![Hoxc9 Is Required for CC Neuron Development\
(A) *In situ* hybridization of marker gene expression in control and *Hoxc9* mutants at P6. Scale bars, 100 μm. Graphs on right show scRNA-seq data (TPM values) for each gene at thoracic levels in control and *Hoxc9* mutants (mean TPM ± SEM, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001).\
(B) Whole-mount images of Alexa555-CTB-labeled SCTNs in control and *Hoxc9* mutants at P6. Images in (A) and (B) are tiled composites generated in Zen and are matted on a black background. Scale bars, 500 μm.\
(C) Sections of Alexa555-CTB-labeled SCTNs at caudal cervical (cCe) and mid-thoracic (mTh) levels. Contour plots are shown on the right. Control cCe, 227cells, n = 8 mice; *Hoxc9*−*/*− cCe, 236 cells, n = 11 samples; Control mTh, 340 cells, n = 8 mice; *Hoxc9*−*/*− mTh, 116 cells, n = 11 mice. Scale bars, 100 μm.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0006){#F5}

![Single-Cell RNA Sequencing of Thoracic SCTNs in Hoxc9 Mutants\
(A) t-SNE visualization of putative joint and separate cell clusters using all cells from both control and *Hoxc9* mutants. Cells were clustered in three sets: (1) control only (as represented in [Figure 3](#F3){ref-type="fig"}), which are labeled as 1--8 on the plot, corresponding to SCT1 through SCT8, (2) mutant-only, which are labeled as m1, m2, m3, m6, and m8 on the plot, and (3) both control and mutant cells; these joint clusters are color-coded on the plot. In general, the joint clusters agree with the independent clustering of control-only and mutant-only cells and suggest the correspondence across the two sets of cells. For example, joint cluster 1 (blue) contains cells mostly from control SCT1 (1) and mutant cluster 1 (m1), while joint cluster 3 (brown) contains cells mostly from control SCT3 (3) and mutant cluster 3 (m3).\
(B) As in [Figure 3C](#F3){ref-type="fig"}, dot plot representing the number of cells in each cluster originating from each control and mutant dissection. For the mutant, each cluster was assigned to its corresponding control SCT cluster, based on the joint clustering shown in (A). The numbers for the control dissections are the same as in [Figure 3C](#F3){ref-type="fig"}.\
(C) Alternative approach to assign *Hoxc9* mutant cells to control clusters. The heatmap shows the classification probabilities for each mutant cell (row) using a random forest classifier trained on the eight control cluster identities (columns). The colorbar on the left indicates the mutant cell cluster identity (m1, m2, m3, m6, and m8). The overall classification closely resembles the result from the joint clustering shown in (A); for example, cells from m1 have high classification scores for control SCT1, whereas cells from m3 tend to be most strongly assigned to SCT3.\
(D) As in [Figure 3D](#F3){ref-type="fig"}, barplot showing expression (TPM) values for selected genes in the cell clusters derived from *Hoxc9* mutant SCTNs.\
See also [Figure S6](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0007){#F6}

![Transformation of SCTN Identity and Connectivity in Hoxc9 Mutants\
(A) Immunostaining of Hoxc8 in retrogradely labeled SCTNs in control and *Hoxc9* mutants in cCe and mTh segments. Thoracic SCTNs express Hoxc8 in *Hoxc9* mutants.\
(B) Quantification of *Hox* gene expression in single cells from control and *Hoxc9* mutant thoracic regions. Solid lines indicate mean; error bars indicate SEM.\
(C) Ectopic expression of Shox2 in thoracic SCTNs of *Hoxc9* mutants.\
(D) Quantification of Shox2^+^ SCTN number and TPM scRNA-seq values of ConC, ConT, and C9−/−T regions. Wilcoxon-Mann-Whitney test, \*p = 0.0167; Con, n = 3, 91cells (Ce, 64; Th, 27)*; Hoxc9*−*/*−, n = 7, 179 cells (Ce, 59; Th, 120). For the Shox2+ cell quantification, cells were counted in regions belong to LVII group according to contour plot in [Figure 1](#F1){ref-type="fig"}.\
(E) Ectopic expression of *Fam19A4* in thoracic sections of *Hoxc9* mutants.\
(F) Quantification of *Fam19A4*+ cells and TPM single-cell values of ConC, ConT, and C9−/−T regions. Wilcoxon-Mann-Whitney test, \*\*\*\*p \< 0.0001; Con, n = 4 (P6, 2; E15.5, 2; 21 sections); *Hoxc9*−*/*−, n = 2 (P6, 1; E15.5, 1; 11 sections).\
(G) Forelimb pSNs synapse with thoracic SCTNs in *Hoxc9* mutants. Middle panels show immunostaining of HRP, CTB, and vGlut1. Right panel shows quantification of synapses between forelimb pSNs and SCTNs. For control cCe, mutant cCe, control mTh, and mutant mTh, synapses were counted in cells belonging to LVII and CC group according to contour plot in [Figure 1](#F1){ref-type="fig"}. Wilcoxon-Mann-Whitney test, \*\*\*\*p \< 0.0001.\
Images in (A), (C), and (G) are tiled composites generated in Zen and are matted on a black background. Scale bars in (A), (C), and (E): 100 mm. See also [Figures S7](#SD1){ref-type="supplementary-material"} and [S8](#SD1){ref-type="supplementary-material"}.](nihms-1530455-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                       SOURCE                    IDENTIFIER
  --------------------------------------------------------- ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                          
  guinea pig anti-Hoxc10                                    This paper                N/A
  rabbit anti-Hoxc6                                         Aviva                     Cat\# ARP38484; RRID:AB_10866814
  rabbit anti-Foxp2                                         Abcam                     Cat\# AB16046; RRID:AB_2107107
  sheep anti-Lrrn1                                          R&D systems               Cat\# AF4990; RRID:AB_2234807
  rabbit anti-Chmp2b                                        Abcam                     Cat\# AB33174; RRID:AB_2079471
  rabbit anti-Syt4                                          Synaptic systems          Cat\# 105043; RRID:AB_887837
  rabbit anti-Ebf3                                          Millipore                 Cat\# AB10525
  rabbit anti-CTB                                           Sigma-Aldrich             Cat\# C3062; RRID:AB_258833
  goat anti-CTB                                             List Biological Lab       Cat\# 703; RRID:AB_10013220
  goat anti-ChAT                                            Millipore                 Cat\# AB144P; RRID:AB_2079751
  guinea pig anti-VgluT1                                    Millipore                 Cat\# AB5905; RRID:AB_2301751
  guinea pig anti-VgluT2                                    Millipore                 Cat\# AB2251; RRID:AB_2665454
  goat anti-Scip                                            SantaCruz                 Cat\# SC11661; RRID:AB_2268536
  rabbit anti-Shox2                                         Thomas Jessell            N/A
  rabbit anti-GFP                                           Thermo Fisher             Cat\# A-6455; RRID:AB_221570
  rabbit anti-Hoxa5                                         [@R15]                    N/A
  rabbit anti-Hoxa10                                        [@R15]                    N/A
  rabbit anti-Hoxc4                                         [@R15]                    N/A
  rabbit anti-Hoxc5                                         [@R15]                    N/A
  mouse anti-Hoxa9                                          [@R15]                    N/A
  guinea pig anti-Hoxc9                                     [@R28]                    RRID: AB_2636809
  guinea pig anti-Hoxc6                                     [@R32]                    RRID: AB_528287
  Alexa 647 anti-Rabbit antibody                            Jackson ImmnoResearch     Cat\# 711-605-152
  Alexa 647 anti-Guinea Pig antibody                        Jackson ImmnoResearch     Cat\# 706-605-148
  Alexa 647 anti-Mouse antibody                             Jackson ImmnoResearch     Cat\# 715-605-150
  Cy3 anti-Guinea Pig antibody                              Jackson ImmnoResearch     Cat\# 706-165-148
  Cy3 anti-Mouse antibody                                   Jackson ImmnoResearch     Cat\# 715-165-150
  Cy3 anti-Rabbit antibody                                  Jackson ImmnoResearch     Cat\# 711-165-152
  Alexa 488 anti-Rabbit antibody                            Jackson ImmnoResearch     Cat\# 711-545-152
  Alexa 488 anti-Guinea pig antibody                        Invitrogen                Cat\# A11073
  Alexa 488 anti-Mouse antibody                             Invitrogen                Cat\# A21202
  anti-DIG-AP Fab fragments                                 Sigma-Aldrich             Cat\# 11093274910
  Bacterial and Virus Strains                                                         
  *AAV-SL1-synGFP*                                          Janelia Research Campus   N/A
  Chemicals, Peptides, and Recombinant Proteins                                       
  Horseradish peroxidase (HRP)                              Sigma-Aldrich             Cat\# 10814407001
  20X SSC                                                   Invitrogen                Cat\# 15557--036
  NBT                                                       Sigma-Aldrich             Cat\# 1383213
  BCIP                                                      Sigma-Aldrich             Cat\# 1383221
  Salmon Sperm DNA                                          Invitrogen                Cat\# 15632--011
  Yeast RNA                                                 Invitrogen                Cat\# AM7118
  Paraformaldehyde                                          Sigma-Aldrich             Cat\# 158127--500G
  UltraPure Formamide                                       Invitrogen                Cat\# 15515--026
  Proteinase K                                              Sigma-Aldrich             Cat\# 03115879001
  Denhardt's Solution (50X)                                 Invitrogen                Cat\# 750018
  Triethanolamine                                           Sigma-Aldrich             Cat\# 33729--1L
  Glycergel                                                 Agilent                   Cat\# C0563
  Vectashield                                               Vector Laboratories       Cat\# H-1200
  Fast Green                                                Sigma-Aldrich             Cat\# F7258
  Hoxc10 peptide: EFEAPFEQRASLNPRTEHC                       Covance                   This paper
  Critical Commercial Assays                                                          
  DIG RNA Labeling Kit (SP6/T7)                             Sigma-Aldrich             Cat\# 11175025910
  Ovation® RNA-Seq System V2                                Nugen                     Cat\# 7102
  Nugen Ovation Ultralow Library System                     Nugen                     Cat\# 0303--05, Cat\# 0330--31
  PicoPure RNA Isolation Kit                                Thermo Fisher             Cat\# KIT0204
  Deposited Data                                                                      
  Bulk SCTN RNaseq data                                     GEO                       GEO: GSE129948
  scRNA-seq data SCTNs                                      GEO                       GEO: GSE130312
  Experimental Models: Organisms/Strains                                              
  Mouse: *Hoxc9 -/-*                                        [@R28]                    MGI:2447619; RRID:MGI:2447619
  Mouse: *Hoxc8-/-;*                                        [@R11]                    N/A
  Mouse: *Nestin::Cre*                                      JAX                       RRID:IMSR_JAX:003771
  Mouse: *Hoxc9 flox/flox*                                  [@R5]                     N/A
  Oligonucleotides                                                                    
  See [Table S1](#SD1){ref-type="supplementary-material"}   This paper                [Table S1](#SD1){ref-type="supplementary-material"}
  Software and Algorithms                                                             
  STAR aligner                                              [@R18]                    <http://code.google.com/p/rna-star/>
  edgeR v3.18.1                                             [@R43]                    [http://bioconductor.org/packages/release/bioc/](http://bioconductor.org/packages/release/bioc/html/edgeR.html)[html/edgeR.html](http://bioconductor.org/packages/release/bioc/html/edgeR.html)
  Zen                                                       Zeiss                     [https://www.zeiss.com/microscopy/us/products/](https://www.zeiss.com/microscopy/us/products/microscope-software/zen.html)[microscope-software/zen.html](https://www.zeiss.com/microscopy/us/products/microscope-software/zen.html)
  Prism v7.0c                                               Graphpad Software         <https://www.graphpad.com/scientific-software/prism/>

###### Highlights

-   Molecular and anatomical characterization of spinocerebellar tract neurons (SCTNs)

-   Segment-specific Hox activity controls SCTN subtype diversification

-   Mutation in Hoxc9 transforms the fate of thoracic Clarke's column SCTNs

-   Hox-dependent programs are essential for spinocerebellar circuit assembly

[^1]: AUTHOR CONTRIBUTIONS

    M.B. performed all of the mouse genetic experiments and histological analyses and isolated SCTNs for RNA-seq. V.M. analyzed the bulk and scRNA-seq data. A.W.H., T.M.J., and J.S.D. designed the experiments. All authors read, edited, and approved the final manuscript.
